# ANGIOMAX RTU
> **NDA211215** · New Drug Application · Sponsor: MAIA PHARMS INC · Approved 2019-07-25
## Drug
- **FDA Application Number:** NDA211215
- **Application type:** New Drug Application
- **Brand name:** ANGIOMAX RTU
- **Generic name:** BIVALIRUDIN
- **Active ingredients:** BIVALIRUDIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MAIA PHARMS INC
- **Manufacturer:** MAIA Pharmaceuticals, Inc.
- **First approval:** 2019-07-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211215)
---
*MORVS · CC0 1.0*